| Supercritical fluid technology for the development of innovative ophthalmic medical devices: Drug loaded intraocular lenses to mitigate posterior capsule opacification K Ongkasin, Y Masmoudi, CM Wertheimer, A Hillenmayer, ... European Journal of Pharmaceutics and Biopharmaceutics 149, 248-256, 2020 | 39 | 2020 |
| Poly (lactic-co-glycolic) acid as a slow-release drug-carrying matrix for methotrexate coated onto intraocular lenses to conquer posterior capsule opacification SA Kassumeh, CM Wertheimer, A von Studnitz, A Hillenmayer, ... Current eye research 43 (6), 702-708, 2018 | 28 | 2018 |
| Evaluation of posterior capsule opacification of the Alcon Clareon IOL vs the Alcon Acrysof IOL using a human capsular bag model A Hillenmayer, CM Wertheimer, S Kassumeh, A von Studnitz, N Luft, ... BMC ophthalmology 20, 1-7, 2020 | 18 | 2020 |
| Combined VEGF/PDGF inhibition using axitinib induces αSMA expression and a pro-fibrotic phenotype in human pericytes J Siedlecki, B Asani, C Wertheimer, A Hillenmayer, A Ohlmann, ... Graefe's Archive for Clinical and Experimental Ophthalmology 256, 1141-1149, 2018 | 17 | 2018 |
| Development of a drug-eluting intraocular lens to deliver epidermal growth factor receptor inhibitor gefitinib for posterior capsule opacification prophylaxis S Kassumeh, A Kueres, A Hillenmayer, A von Studnitz, C Elhardt, ... European Journal of Ophthalmology 31 (2), 436-444, 2021 | 15 | 2021 |
| Galectin-1 and -3 in high amounts inhibit angiogenic properties of human retinal microvascular endothelial cells in vitro A Hillenmayer, CM Wertheimer, A Geerlof, KH Eibl, S Priglinger, ... Plos one 17 (3), e0265805, 2022 | 5 | 2022 |
| Inhibition of proliferative vitreoretinopathy by a newly developed methotrexate loaded drug carrier in vitro SS Arrow, SC Felis, A Hillenmayer, LD Strehle, SF Koenig, ... Biomedicine & Pharmacotherapy 158, 114088, 2023 | 4 | 2023 |
| Epiretinal amniotic membrane in complicated retinal detachment: a clinical and in vitro safety assessment A Hillenmayer, CM Wertheimer, MJ Gerhard, SG Priglinger, A Ohlmann, ... Ophthalmology and Therapy 12 (3), 1635-1648, 2023 | 2 | 2023 |
| In vitro evaluation of simulated stereotactic radiotherapy for wet age-related macular degeneration on three different cell lines E Vounotrypidis, A Hillenmayer, CM Wertheimer, A Athanasiou, ... Scientific Reports 11 (1), 8068, 2021 | 1 | 2021 |
| Epiretinal Amniotic Membrane Influences the Cellular Behavior of Profibrotic Dedifferentiated Cells of Proliferative Vitreoretinopathy In Vitro A Hillenmayer, LD Strehle, C Hilterhaus, A Ohlmann, CM Wertheimer, ... Journal of Tissue Engineering and Regenerative Medicine 2023, 2023 | | 2023 |
| Die inhibitorische Wirkung exogener Galektine-1 und-3 auf humane retinale mikrovaskuläre Endothelzellen A Hillenmayer lmu, 2022 | | 2022 |
| Analysis of intraocular amniotic membrane in vitreoretinal disease with complicated retinal detachment-case reports and in-vitro safety assessment. A Hillenmayer, CM Wertheimer, MJ Gerhard, SG Priglinger, A Ohlmann, ... | | 2022 |
| Human recombinant Galectin-1 mitigates the cellular mechanisms of proliferative vitreoretinopathy in primary human tractive membranes in-vitro A von Studnitz, C Wertheimer, A Hillenmayer, A Geerlof, S Kassumeh, ... Investigative Ophthalmology & Visual Science 60 (9), 6417-6417, 2019 | | 2019 |
| The role of lectines galectin-1 and 3 during the development of retinal vasculogenesis A Hillenmayer, C Wertheimer, S Kassumeh, C Priglinger, S Priglinger, ... Investigative Ophthalmology & Visual Science 60 (9), 1645-1645, 2019 | | 2019 |
